Immune-Onc Therapeutics Stock

immune-onc.comHealthcare / BioTech & PharmaFounded: 2016Funding to Date: $143.15MM

Immune-Onc Therapeutics is a clinical-stage developer of novel biotherapeutics for cancer patients.

Register for Details

For more details on financing and valuation for Immune-Onc Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Immune-Onc Therapeutics.

Register Today

Other companies like Immune-Onc Therapeutics in the BioTech & Pharma sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$8.45B
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$8.84B
Sector
Last Round Est. Valuation
$303.94MM
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$4.74B